AGM Statement

Advanced Medical Solutions Grp PLC
19 May 2004


For Immediate Release                                    Wednesday 19th May 2004



                         Advanced Medical Solutions Group plc
 
                           Annual General Meeting Statement


Winsford, UK: Advanced Medical Solutions (AIM: AMS), the global woundcare
technology company, is holding its Annual General Meeting at 11:00 am today.


Don Evans, Chief Executive, will give a business update presentation, a copy of
which is posted on the web site www.admedsol.com.


Commenting on current trading, Chairman Dr. Geoffrey Vernon stated:



'The outlook for 2004 is positive.  The strong start to the year has continued
into the 2nd quarter and we remain on track to come through to profitability
within current cash in line with market expectations.'


                                     -ENDS-


For further information, please contact:


Advanced Medical Solutions Group plc               Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com


Buchanan Communications                            Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:


Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.



Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.



In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.



The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or
through distributors.



AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson Inc,
Molnlycke Healthcare, Coloplast, Smith & Nephew and Beiersdorf.
--------------------------



                      This information is provided by RNS
            The company news service from the London Stock Exchange